Johnson & Johnson (JNJ) Tops Q1 EPS by 9c; Raises FY11 Outlook
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $231.29 +1.27%
Revenue Growth %: +5.1%
Financial Fact:
Other (income) expense, net: -54M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +5.1%
Financial Fact:
Other (income) expense, net: -54M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $1.35, $0.09 better than the analyst estimate of $1.26. Revenue for the quarter came in at $16.2 billion versus the consensus estimate of $15.83 billion.
Raises its FY11 EPS guidance to $4.90-$5, vs. the consensus of $4.83. The company had previously guided to $4.80-$4.90.
Raises its FY11 EPS guidance to $4.90-$5, vs. the consensus of $4.83. The company had previously guided to $4.80-$4.90.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- Johnson & Johnson invests $1 billion in Jacksonville vision manufacturing
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
